NIPH Clinical Trials Search

JRCT ID: jRCT1032210196

Registered date:14/07/2021


Basic Information

Recruitment status Complete
Health condition(s) or Problem(s) studiedHealth Condition(s) or Problem(s) Studied Colon cancer
Date of first enrollment24/08/2021
Target sample size41
Countries of recruitment
Study typeInterventional
Intervention(s)Robotic right-hemicolectomy


Primary OutcomePostoperative complications within 30 days after surgery
Secondary Outcome1. Conversion rate 2. Readmission rate within 30 days after surgery 3. Mortality rate within 30 days after surgery 4. Intraoperative adverse events (vascular damage / organ damage / reconstruction / other) 5. Postoperative recovery (postoperative hospital stay, time to first flatus, time to first oral intake) 6. Surgical results (blood loss, operative time, console time, harvested lymph node number, R0 resection rate)

Key inclusion & exclusion criteria

Age minimum>= 20age old
Age maximumNot applicable
Include criteria1. Patients over 20 years old age 2. Histologically, diagnosed with colon cancer 3. Preoperative diagnosis of curative primary resection 4. Main tumor site is cecum (C), ascending colon (A) or right-sided transverse colon (T) and right-hemicolectomy with D2 or higher lymph node dissection is pre-planned 5. Clinical stage I to IIIC (T1-4b, N0-2b, M0: TNM Classification) has been diagnosed 6. Patients who are diagnosed out of the endoscopic resection 7. Patients with tumor maximum diameter of 8 cm or less 8. Patients who do not recognize multiple lesions that require two or more anastomosis places 9. Patients with ECOG Performance Status (PS) score of 0 to 1 10. Patients who have the judgment to fully understand the research content. 11. Patients with written informed consent to participate in this study.
Exclude criteria1. Patients with chemotherapy (systemic anti-cancer drug treatment) and a history of radiation therapy, including treatment for other cancer species. 2. Patients who have a history of open surgery 3. Patients who have a history of laparoscopic stomach resection or colectomy 4. Patients with the latest check values within 14 days before registration meet the following Leukocyte <3000 / mm 3, Platelet <75,000 / mm 3, Hemoglobin <7 G / DL, AST> 100 IU / L, ALT> 100 IU / L, Serum Cr> 1.5 mg / dl. 5. Other patients who are judged to be unsuitable as a subject by the doctor's judgment.

Related Information


Public contact
Name Jun Watanabe
Address 4-57 Urafune, Minami-ku, Yokohama Kanagawa Japan 232-0024
Telephone +81-45-261-5656
Affiliation Yokohama City University Medical Center
Scientific contact
Name Atsushi Ishibe
Address 3-9 Fukuura, Kanazawa-ku, Yokohama Kanagawa Japan 236-0004
Telephone +81-45-787-2800
Affiliation Yokohama City University Hospital